TBPH
Theravance Biopharma Inc

1,028
Mkt Cap
$924.77M
Volume
1.35M
52W High
$21.03
52W Low
$7.90
PE Ratio
32.44
TBPH Fundamentals
Price
$18.25
Prev Close
$18.19
Open
$18.02
50D MA
$19.26
Beta
0.53
Avg. Volume
381,994.50
EPS (Annual)
-$1.16
P/B
3.97
Rev/Employee
$663,721.65
$421.12
Loading...
Loading...
News
all
press releases
CRMD vs. TBPH: Which Small-Cap Biotech Stock Is the Better Bet?
CorMedix and Theravance take sharply different routes to small-cap biotech growth - one fueled by sales traction, the other by pipeline promise.
Zacks·6d ago
News Placeholder
More News
News Placeholder
Hillsdale Investment Management Inc. Purchases New Position in Theravance Biopharma, Inc. $TBPH
Hillsdale Investment Management Inc. acquired a new stake in Theravance Biopharma, Inc. (NASDAQ:TBPH - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the...
MarketBeat·7d ago
News Placeholder
Theravance Biopharma (TBPH) to Release Earnings on Wednesday
Theravance Biopharma (NASDAQ:TBPH) will be releasing its Q4 2025 earnings before the market opens on Wednesday, February 25. (View Earnings Report at...
MarketBeat·12d ago
News Placeholder
Baader Bank Aktiengesellschaft Invests $781,000 in Theravance Biopharma, Inc. $TBPH
Baader Bank Aktiengesellschaft bought a new stake in Theravance Biopharma, Inc. (NASDAQ:TBPH - Free Report) during the third quarter, according to the company in its most recent disclosure with the...
MarketBeat·18d ago
News Placeholder
Theravance Biopharma, Inc. (NASDAQ:TBPH) Receives Average Recommendation of "Buy" from Brokerages
Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH - Get Free Report) have earned a consensus rating of "Buy" from the seven analysts that are covering the company, MarketBeat.com reports. Two...
MarketBeat·21d ago
News Placeholder
Theravance Biopharma's (TBPH) "Buy" Rating Reaffirmed at BTIG Research
BTIG Research reaffirmed a "buy" rating and issued a $40.00 price target on shares of Theravance Biopharma in a research note on Tuesday...
MarketBeat·27d ago
News Placeholder
Noteworthy Wednesday Option Activity: TBPH, APH, LQDA
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Theravance Biopharma, Inc. (Symbol: TBPH), where a total of 2,009 contracts have traded so...
Nasdaq News: Markets·1mo ago
News Placeholder
Is the Options Market Predicting a Spike in Theravance Biopharma Stock?
Investors need to pay close attention to TBPH stock based on the movements in the options market lately.
Zacks·1mo ago
News Placeholder
Why Theravance Biopharma (TBPH) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks·1mo ago
News Placeholder
Theravance Biopharma (NASDAQ:TBPH) Reaches New 1-Year High - Here's What Happened
Theravance Biopharma (NASDAQ:TBPH) Hits New 52-Week High - What's Next...
MarketBeat·1mo ago
<
1
2
...
>

Latest TBPH News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.